Correlation Between Bristol-Myers Squibb and Lithium One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Lithium One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Lithium One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Lithium One Metals, you can compare the effects of market volatilities on Bristol-Myers Squibb and Lithium One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Lithium One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Lithium One.

Diversification Opportunities for Bristol-Myers Squibb and Lithium One

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Bristol-Myers and Lithium is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Lithium One Metals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lithium One Metals and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Lithium One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lithium One Metals has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Lithium One go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Lithium One

Assuming the 90 days horizon Bristol-Myers Squibb is expected to generate 4.39 times less return on investment than Lithium One. But when comparing it to its historical volatility, Bristol Myers Squibb is 4.15 times less risky than Lithium One. It trades about 0.07 of its potential returns per unit of risk. Lithium One Metals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  7.83  in Lithium One Metals on November 28, 2024 and sell it today you would lose (6.71) from holding Lithium One Metals or give up 85.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy30.79%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Lithium One Metals

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Lithium One Metals 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Lithium One Metals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting technical and fundamental indicators, Lithium One reported solid returns over the last few months and may actually be approaching a breakup point.

Bristol-Myers Squibb and Lithium One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and Lithium One

The main advantage of trading using opposite Bristol-Myers Squibb and Lithium One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Lithium One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lithium One will offset losses from the drop in Lithium One's long position.
The idea behind Bristol Myers Squibb and Lithium One Metals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences